Technology Solutions

Three Questions: Mika Lindroos, CRF Health

Monday, September 19, 2016

CWWeekly presents this feature as a spotlight on issues faced by executives in clinical research. This week, writer Karyn Korieth spoke with Mika Lindroos, director of product management at CRF Health, which provides electronic Clinical Outcome Assessment (eCOA) solutions for global clinical trials.

[Read More]

Inspirata acquires Precision Medicine Network

Wednesday, September 14, 2016

Cancer diagnostics and digital pathology workflow solution provider Inspirata has acquired the assets of Boston-based Precision Medicine Network, including its products and the associated intellectual property. This includes “Crosswalk Insight: Oncology,” a precision medicine knowledge visualization and decision support platform. Inspirata plans to integrate Crosswalk with its Digital Pathology Cockpit and its Cancer Information Data Trust (CIDT) to enhance the precision medicine tools and services available in these products.

[Read More]

Federal prize competition seeks innovative ideas to combat antimicrobial resistance

Tuesday, September 13, 2016

A federal prize competition launched calling for innovative ideas for rapid, point-of-care laboratory diagnostic tests to combat the development and spread of drug resistant bacteria, a rising public health threat. Antibiotic resistant bacteria cause at least 2 million infections and 23,000 deaths each year in the U.S., according to the Centers for Disease Control and Prevention.

[Read More]

Certara acquires d3 Medicine

Thursday, September 8, 2016

Certara, a provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, has acquired d3 Medicine. d3 Medicine, which is based in Parsippany, New Jersey, and Melbourne, Australia, provides strategic planning and stewardship of complex drug development programs.

[Read More]

Medidata, SHYFT Analytics partner

Wednesday, September 7, 2016

Medidata and SHYFT Analytics have announced a strategic commercial partnership to increase access to healthcare data analytics in clinical trials. The partnership will enable life sciences companies to add real world evidence (RWE) data from electronic medical records (EMRs) and health claims to information traditionally collected in clinical trials, providing a more comprehensive view of patient health.

[Read More]

Illumina, FlowJo partner for single cell genomics

Monday, August 15, 2016

Illumina and FlowJo have partnered to develop and co-market analysis software for single cell next-generation sequencing (NGS) data. Under the agreement FlowJo, the producer of FlowJo, software for single cell analysis, will develop a new software application. It will provide additional secondary and tertiary analysis and visualization of datasets with an intuitive approach built on 19 years of experience working with cell biologists and immunologists in single cell phenotyping. The application will seamlessly integrate with Illumina’s Single Cell RNA BaseSpace app, and provide a solution accelerating discovery.

[Read More]

Certara updates PK/PD Phoenix Software

Wednesday, August 10, 2016

Certara, a provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, has announced the launch of Phoenix 7.0. Phoenix is the most advanced, intuitive, and widely-used software for pharmacokinetic (PK), pharmacodynamic (PD), and toxicokinetic (TK) modeling and simulation.

[Read More]